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ABSTRACT
Introduction: Acute respiratory tract infections are the most common illness in all individuals. 
Rhinoviruses have been reported as the etiology of more than 50% of respiratory tract 
infections worldwide. The study prospectively evaluated 47 elderly individuals from a group 
of 384 randomly assigned for acute respiratory viral infections (cold or flu) and assessed the 
occurrence of human rhinovirus (HRV), influenza A and B, respiratory syncytial virus and 
metapneumovirus (hMPV) in Botucatu, State of São Paulo, Brazil. Methods: Forty-nine 
nasal swabs collected from 47 elderly individuals following inclusion visits from 2002 to 2003 
were tested by GenScan RT-PCR. HRV-positive samples were sequenced for phylogenetic 
analysis. Results: No sample was positive for influenza A/B or RSV. HRV was detected in 
28.6% (14/47) and hMPV in 2% (1/47). Of 14 positive samples, 9 isolates were successfully 
sequenced, showing the follow group distribution: 6 group A, 1 group B and 2 group C 
HRVs. Conclusions: The high incidence of HRV during the months of the influenza season 
requires further study regarding HRV infection impact on respiratory complications among 
this population. Infection caused by HRV is very frequent and may contribute to increasing 
the already high demand for healthcare during the influenza season. 
Keywords: Respiratory viruses. Human rhinovirus. Genescan RT-PCR. Reverse transcription 
polymerase chain reaction. Elderly.
RESUMO
Introdução: Infecções agudas do trato respiratório estão entre as doenças mais comuns em 
todas as pessoas. Os rinovírus têm sido descritos como agente etiológico de mais de 50% 
das infecções do trato respiratório ao redor do mundo. O objetivo deste trabalho foi avaliar 
a ocorrência de rinovírus humano (HRV), influenza vírus A e B, vírus respiratório sincicial 
humano e metapneumovírus (hMPV) em uma população de idosos que apresentava sintomas 
de gripe ou resfriado, e que residiam na Cidade de Botucatu, Estado de São Paulo, Brasil. 
Métodos: Foram coletados swabs nasais de 47 idosos após visitas de inclusão, entre os anos 
de 2002 e 2003 e que foram testadas através de GeneScan RT-PCR. Resultados: HRV foi 
detectado em 28.6% (14/47) e hMPV em 2% (1/47). De 14 amostras positivas para HRV, 
9 foram sequenciadas, mostrando a seguinte distribuição de grupos: grupo A: 6 amostras, 
grupo B: 1 amostra e grupo C: 2 amostras. Conclusões: A alta incidência de HRV durante 
os meses de ocorrência de gripe necessita de estudos posteriores para avaliar o impacto desse 
vírus entre os idosos. A alta frequência de HRV pode contribuir para o aumento da demanda 
por serviços de saúde durante a estação de influenza.
Palavras-chaves: Viroses respiratórias. Rinovírus humano. Genescan RT-PCR. Reação em 
cadeia da polimerase. Idosos.
The elderly show increased susceptibility to 
respiratory infections and related complications1. 
On average, community-dwelling elderly individuals 
suffer from 1.2 to 1.6 acute respiratory infections 
per year2,3. The role of influenza virus in severe 
disease among the elderly population is well 
described throughout the world. Until recently, the 
possible contribution of respiratory viruses other 
than influenza has attracted little attention and 
has probably been underestimated. Some studies 
indicate that respiratory syncytial virus (RSV) and 
human metapneumovirus (hMPV) have a greater 
role in respiratory tract infections of the elderly4,5 
and a recently paper from Louie et al6 described an 
association between high mortality and an outbreak 
of human rhinovirus (HRV) in a long-term care 
facility for elderly individuals. Indeed, laboratory 
diagnosis of acute respiratory infections (ARI) in 
symptomatic elderly individuals has focused almost 
exclusively on institutionalized elderly individuals7-9 
and patients seeking medical consultation10,11. Thus, 
remarkably little is known regarding respiratory viral 
infections among the elderly living in the community2. 
Such studies have shown that rhinoviruses cause 
the great majority of these respiratory illnesses. 
Advances in diagnostic techniques have enabled 
more complete identification of the viruses involved 
in respiratory infections12.
In Brazil, the National Influenza Immunization 
Program has included the elderly since 1995 
and influenza surveillance has been systematic 
established recently but no data are available 
regarding the presence of other respiratory pathogens 
in community-dwelling elderly individuals in 
Brazil13. 
The purpose of this study was to evaluate the 
occurrence of human rhinovirus, influenza A and B, 
respiratory syncytial virus and metapneumovirus 
among the elderly population presenting flu or cold 
symptoms in Botucatu, State of São Paulo, Brazil. 
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RESULTS
METHODS
Subjects
In a previous study14, 384 elderly were followed during the winter 
months to evaluate the appearance of respiratory acute symptoms. 
This study was conducted using a systematic random sample 
(n = 384) of the elderly population of the urban area of Botucatu, 
a city of 130 thousand inhabitants in the central-western region of 
the State of São Paulo. The initial choice of the samples was based 
on a registry of 9,000 families for a population-based study of work 
accidents in the municipality14. Criteria for the inclusion of randomly 
selected subjects in the study were as follows: age 60 years-old or 
over, living in Botucatu, at home during one of the three attempted 
home visits, not institutionalized and agreeing to participate in the 
survey by providing written informed consent. Of the total number 
of individuals, 365 were interviewed and 47 patients contacted the 
research group reporting acute respiratory symptoms; a nasal swab 
was collected in a subsequent visit. Forty-nine nasal swabs from 
47 symptomatic elderly individuals, presenting symptoms for up to 
7 days, who participated in household survey study and who 
contacted the group after the inclusion visits, were collected during 
years of 2002 and 2003 for the virological study. A questionnaire was 
also completed to obtain demographic and clinical data and evaluate 
the immunization status of the individuals. 
Clinical specimens were processed and separated in two aliquots: 
one for molecular methods (Influenza A/B, RSV, hMPV and HRV) 
and other for viral isolation (influenza A/B and RSV). 
Viral isolation
All specimens were processed on the day of their collection and 
treated with antibiotics. One hundred microliters were inoculated 
into 2 monolayer wells each of Hep-2 and MDCK cells cultured in 24-
well polystyrene microplates (Corning, New York, NY). All cultures 
were incubated at 37ºC and examined every day for the cytopathic 
effect (CPE) over a period of 12 days. Two blind cell passages were 
performed independent of the appearance of the CPE. The presence 
of respiratory viruses was suggested by CPE. Independent of the 
presence or absence of CPE, all medium passages were collected for 
nucleic acid extraction and subsequent GeneScan analysis.
Nucleic acid extraction
Aliquots (250µl) of each specimen and medium supernadant 
cell culture were dispensed into a tube, each containing 750µl of 
Trizol-LS (Invitrogen, Carlsbad, CA) and frozen at -70ºC until their 
extraction. Total RNA/DNA extraction by Trizol was performed 
in accordance with the manufacturer’s instructions. Nucleic acid 
extracts were diluted with 50µl of ultrapure nuclease free water 
(Invitrogen, Carlsbad, CA) containing RNAse inhibitor (RNAguard; 
Applied Biosystems, Foster City, CA) at a final concentration of 
1U/µl. Extracts were transcribed into cDNA immediately or stored 
at -70ºC. Reverse transcription was performed using SuperScript 
III Transcriptase Reverse (Invitrogen, Carlsbad, CA) and random 
primers (Invitrogen, Carlsbad, CA).
GeneScan for influenza A/B, human respiratory syncytial 
virus and human metapneumovirus
The RT-PCR GeneScan method for influenza A and B, respiratory 
syncytial virus and metapneumovirus was performed as described 
elsewhere15. This technique uses a positive strand primer 5'-end-
labeled with fluorescent6-carboxyfluorescein (6-FAM). Following 
RT-PCR, amplified products of each specimen were pooled and 
purified by precipitation with ethanol to remove the excess salt. 
Amplicon analysis was then performed on an ABI Prism 310 
Genetic Analyzer (Applied Biosystems) with GeneScan software 
(version3.1.2), using a 47cm capillary with POP-4TM polymer. 
Electropherograms were examined and specimens showing discrete 
amplicon peaks within ≤ 1 nucleotides of the respective positive 
control peak were considered positive. 
RT-PCR for human rhinovirus
RT-PCR for HRV was performed as described elsewhere16, 
with minor modifications. The eluted RNA was transcribed into 
cDNA with Moloney Murine Reverse Transcriptase (MMLV-RT; 
Invitrogen, Carlsbad, CA) and virus specific oligonucleotide primer, 
for 1h at 37°C. Following MMLV-RT denaturation at 70°C, virus-
specific oligonucleotide primer and Platinum Taq DNA Polymerase 
(Invitrogen, Carlsbad, CA) were added and 40 cycles of PCR were 
run, consisting of denaturation (45 sec at 95°C), annealing (45 
sec at 61°C) and DNA extension (1 min at 72°C). RT-PCR targets 
the hypervariable part of the 5’NCR, the entire VP4 gene and 
the 5’ terminus of the VP2 gene. RT-PCR was standardized with 
sensitivity of 10-3,25 TCID50/100µL. The presence of PCR products 
was visualized by agarose gel electrophoresis according to their 549bp 
molecular weight. Positive (HRV 39) and negative water controls 
were tested in all reactions.
Purification and sequencing of human rhinovirus PCR 
products
The PCR products were purified using a ChargeSwitch PCR 
Clean-Up Kit (Invitrogen, Carlsbad, CA) and sequenced in both 
directions using the Sanger dideoxy cycle-sequencing method with 
the ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction 
Kit, in accordance with the manufacturer’s instructions, using the 
3130XL Genetic Analyzer (Applied Biosystems, Foster City, CA).
Sequence alignment and phylogenetic analyses
Multiple sequences were aligned using Clustal X (v2.0.11). The 
multiple-sequence alignment was subjected to phylogenetic analyses 
using the program TOPALi (v2.5). Phylogenetic relationships 
were assessed using neighbor-joining, maximum-parsimony 
and maximum-likelihood methods. Forty-nine published HRV 
sequences within the VP4-VP2 were obtained from the GenBank 
database (NCBI) and used as reference. 
Ethical considerations
This study was approved by the Research Ethics Committee of 
Botucatu Medical School according to resolution no. OF. 42/2006 
CEP and written consent was obtained from all elderly individuals. 
Overall influenza immunization coverage in this recruited population 
(n = 365) was 62.3%. In the 47 symptomatic elderly individuals, 
patients that contacted the research group, age ranged from 60 to 85 
years-old, with a median age of 69 years-old and a mean age 70 years-
old (±7.16 years). The proportion of males and females was 29.8% 
and 70.2%, respectively. Coryza, sore throat and cough were common 
symptoms (69%, 62.1% and 51.7% respectively; n = 29); however, 
no clinical information was available for 18 patients. The vaccine rate 
in 2002 was 66.7% among this patients (n = 39 with information).
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FIGURE 1 - Samples collected and positive cases during the study period.
FIGURE 2 - A neighbor-joining phylogenetic tree analysis of the VP4/VP2 region 
of 9 HRV strains from Botucatu, State of São Paulo, Brazil and 48 prototype 
HRV group from GenBank (access number follow abbreviations Rhino A, B 
and C) showing their grouping into three HRV species: •= HRV-A, •= HRV-B, 
•=  HRV-C,   =  outgroup (echo 11).o
Viral detection
Of the 49 samples tested by different molecular assays 15 (30.6%) 
were positive: rhinovirus was detected in 14 (28.6%) samples and 
hMPV in one (2%) sample. None of the samples were positive for 
influenza A/B or RSV by the GeneScan assay or cell culture. Regarding 
HRV infections, 9/14 (64.3%) occurred during the influenza season: 
in five cases, samples were collected during winter months, 4 in the 
autumn, 4 in summer months and 1 during spring. Figure 1 shows 
the samples collected and positive cases over the study period.
Phylogenetic analysis of clinical HRV isolates
To evaluate the ability of the assay to genotype HRVs, a total of 
14 unknown clinical respiratory isolates were sequenced. Nine 
isolates were successfully sequenced and identified. A total of 6 (66%) 
HRVs were identified for group A, 1 for group B (11%) and 2 (22%) 
for group C. Figure 2 depicts the maximum likelihood tree showing 
the pattern of distribution of Brazilian isolates into three main 
clusters, representing the HRV species A, B, and C. To strengthen 
this analysis, homologous sequences of the main HRV species isolates 
were used as species references (the GenBank identities of these 
references are shown in the tree) (Figure 2).
This first study assessing viral etiologies among symptomatic 
elderly individuals in the influenza immunized community in Brazil 
verified 30% viral detection by different molecular assays. Donalísio 
et al14 described a vaccine coverage of 63.2% in elderly individuals 
from Botucatu, SP, Brazil in 2002. A total of 384 individuals 
were initially recruited from a databank of 9,000 family, but only 
47 (12.4%) contacted the research team following the inclusion visit. The 
individuals selected (n=384) are likely to be representative of the elderly 
population in the region, despite the low number of samples collected. 
In the present study, HRV was the most frequently detected 
agent. HRV infections are common among patients, including the 
elderly, and account for 25 to 50% of respiratory illnesses among 
community-dwelling elderly individuals2. Few reports exist in 
Brazil regarding rhinovirus respiratory infections. In a recent study, 
the authors verified that HRV infections were very frequent in the 
Brazilian adult population, resulting in more severe presentation that 
the common cold. Bellei et al17 reported that approximately 50% of 
HRV-infected individuals presented influenza-like illness and that it 
was circulating in the same period as influenza. 
Complications due to HRV infection seem to be more frequent 
in the elderly, particularly in home care services. In two studies 
conducted at nursing homes and long-term care facilities for the 
elderly, outbreaks were described with mortality rates varying of 
6 to 21%. In both studies, the deaths were directly attributed to acute 
infection caused by HRV6,18.
HRV phylogenetic analyses show a distribution of groups 
coherent with the literature. An interesting fact was observed 
regarding HRV C. The first study describing this new HRV group 
was conducted in mid 200619. Thus, it was very surprising that HRV 
C was detected infecting a patient as early as 2003. This original 
data supports the hypothesis that this new group had been already 
circulating before the study by Lamson et al19. 
Falsey et al5 described a frequency of 1.7% for hMPV infection 
in symptomatic elderly individuals. In this study, a frequency of 2% 
was determined, in agreement with the literature. 
Influenza and RSV usually cause complications in the elderly 
population, but in this study, neither of them were detected. The 
sensitivity of GeneScan RT-PCR for Influenza virus, RSV and 
hMPV is very high, described by Erdman et al as a sensitive and 
specific method for viral detection20. During 2002 and 2003, low 
activity of influenza virus in the elderly population in the community 
was described in the city of São Paulo, Brazil21. High influenza 
immunization adherence and variability in activity of the RSV 
pattern22 are implicated in the current data. RSV activity can be 
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